Home › TransCelerate selects Cognizant to develop first-of-its-kind, subscription-based platform
 

Keywords :   


TransCelerate selects Cognizant to develop first-of-its-kind, subscription-based platform

2014-07-25 09:03:06| IT Services - Topix.net

Cognizant today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with pharmaceutical companies on clinical trials.

Tags: develop platform selects cognizant

Category:Information Technology

Latest from this category

All news
»
23.09Price Ranch earns RAAA 2024 Commercial Producer of the Year
23.09Tropical Storm John Update Statement
23.09Summary for Tropical Storm John (EP5/EP102024)
23.09Is the Budget's bite going to be rather less painful than its bark?
23.09Flushability Standard Introduced in China
23.09Union boss questions Amazon public contracts
23.09Texas Landowners Advocate for Major Changes to Oilfield Waste Disposal Procedures
23.09Long Islands Waste Future Uncertain as Landfill Closure Looms
More »